LUMOS PHARMA INC (LUMO) Stock Balance Sheet
NASDAQ:LUMO - Nasdaq - US55028X1090 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.52M | 35.08M | 56.00M | 94.80M | 98.70M | |||
| Marketable Securities | 0.00 | 999.00K | 11.40M | N/A | N/A | |||
| Receivables | 174.00K | 210.00K | 200.00K | 100.00K | 26.30M | |||
| Other Current Assets | 3.58M | 3.75M | 4.40M | 4.70M | 3.50M | |||
| Total Current Assets | 17.27M | 40.03M | 72.00M | 99.70M | 128.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 187.00K | 603.00K | 300.00K | 600.00K | 600.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 187.00K | 603.00K | 300.00K | 600.00K | 600.00K | |||
| TOTAL ASSETS | 17.46M | 40.64M | 72.30M | 100.30M | 129.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 5.05M | 6.14M | 6.40M | 4.50M | 6.20M | |||
| Accounts Payable | 1.46M | 890.00K | 300.00K | 600.00K | 200.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 6.50M | 7.03M | 6.70M | 5.10M | 6.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 6.04M | 6.30M | 6.00M | 6.20M | 6.00M | |||
| Total Non-Current Liabilities | 6.04M | 6.30M | 6.00M | 6.20M | 6.00M | |||
| TOTAL LIABILITIES | 12.55M | 13.33M | 12.70M | 11.30M | 12.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -186.98M | -161.52M | -127.50M | -96.40M | -66.00M | |||
| Additional Paid In Capital | 192.02M | 188.94M | 187.20M | 185.40M | 182.50M | |||
| Common Shares | 86.00K | 81.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -215.00K | -196.00K | -200.00K | -100.00K | N/A | |||
| Other Shareholders' Equity | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Shares Outstanding | 8.65M | 8.10M | 8.30M | 8.40M | 8.30M | |||
| Tangible Book Value per Share | 0.57 | 3.37 | 7.18 | 10.60 | 14.05 | |||
| Total Shareholders' Equity | 4.91M | 27.30M | 59.60M | 89.00M | 116.60M | |||
| TOTAL LIABILITIES AND EQUITY | 17.46M | 40.64M | 72.30M | 100.30M | 129.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.66 | 5.69 | 10.75 | 19.55 | 19.75 | |||
| Return On Assets (ROA) | -199.97% | -83.75% | -43.02% | -30.31% | -4.88% | |||
| Return On Equity (ROE) | -710.54% | -124.64% | -52.18% | -34.16% | -5.40% | |||
All data in USD , ROIC based on taxRate of 0.21